Evidence map›Paper›PMID 34982109›Full record

ArticleJournal of cell science2022

Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins.

Gianna M Fote, Nicolette R Geller, Nikolaos E Efstathiou, Nathan Hendricks, Demetrios G Vavvas, Jack C Reidling, Leslie M Thompson, Joan S Steffan

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  13. Article
  14. Article
  15. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  16. Article
  17. The cell biology of APOE in the brain.Trends in cell biology · 2024
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Gianna M FoteUC Irvine Department of Biological Chemistry, 825 Health Sciences Road, Medical Sciences I, Room D240, UC Irvine School of Medicine, Irvine, CA 92697-1700, USA.
Nicolette R GellerUC Irvine Department of Psychiatry and Human Behavior, Neuropsychiatric Center, UC Irvine Medical Center, 101 The City Drive South, Building 3, Route 88, Orange, CA 92868, USA.
Nikolaos E EfstathiouHarvard Medical School Department of Ophthalmology, 243 Charles Street, Boston, MA 02114, USA.
Nathan HendricksInstitute for Integrative Genome Biology, UC Riverside, Eucalyptus Drive, Riverside, CA 92521, USA.
Demetrios G VavvasHarvard Medical School Department of Ophthalmology, 243 Charles Street, Boston, MA 02114, USA.
Jack C ReidlingUC Irvine MIND Institute, 2642 Biological Sciences III, Irvine, CA 92697-4545, USA.
Leslie M ThompsonUC Irvine Department of Biological Chemistry, 825 Health Sciences Road, Medical Sciences I, Room D240, UC Irvine School of Medicine, Irvine, CA 92697-1700, USA.
Joan S SteffanUC Irvine Department of Psychiatry and Human Behavior, Neuropsychiatric Center, UC Irvine Medical Center, 101 The City Drive South, Building 3, Route 88, Orange, CA 92868, USA.ORCID 0000-0003-2467-6294
University of California, Irvine · USHarvard University · USUC Irvine Health · USUniversity of California, Riverside · US

Funding

UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
Training in the Neurobiology of Aging and Alzheimers DiseaseT32AG000096 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI VIVEK SWARUP, Craig E Stark · 1985 to 2026
$9.6M
Molecular Mechanisms of Pathogenesis in Huntington’s diseaseR35NS116872 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Leslie Michels Thompson · 2020 to 2026
$8.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008620 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GOLDIN, ALAN L · 1999 to 2023
$8.1M
Neuroregulatory Mechanisms of PIAS1 and Implications for Huntington's DiseaseR01NS090390 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAVIDSON, BEVERLY L., THOMPSON, LESLIE MICHELS · 2015 to 2018
$1.8M
Pathogenic impact of Huntington phosphorylation in Huntington's DiseaseR01NS072453 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI STEFFAN, JOAN SAWYER · 2012 to 2015
$1.3M
An LTQ-Orbitrap Elite with ETD for the Keck Proteomics FacilityS10OD010669 · OD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI WANG, YINSHENG · 2013 to 2013
$600k
Neuroregulatory Mechanisms of PIAS1 and Implications for Huntington's DiseaseR56NS090390 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI THOMPSON, LESLIE MICHELS · 2014 to 2014
$565k
Pathogenic impact of Huntingtin phosphorylation in Huntington's DiseaseR56NS072453 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI STEFFAN, JOAN SAWYER · 2017 to 2017
$377k
Defining the Function of APOE in Autophagy and NeurodegenerationF30AG060704 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI FOTE, GIANNA · 2019 to 2021
$131k
NIA NIH HHS F30 AG060704NIA NIH HHS P50 AG016573NIA NIH HHS T32 AG000096NIGMS NIH HHS T32 GM008620NIH HHS 1F30AG060704NIH HHS 1F30AG060704-01A1NIH HHS NS116872NIH HHS S10 OD010669NINDS NIH HHS R01 NS072453NINDS NIH HHS R01 NS090390NINDS NIH HHS R35 NS116872NINDS NIH HHS R56 NS072453NINDS NIH HHS R56 NS090390
6 · The paper itself

Abstract

The human apolipoprotein E4 isoform (APOE4) is the strongest genetic risk factor for late-onset Alzheimer's disease (AD), and lysosomal dysfunction has been implicated in AD pathogenesis. We found, by examining cells stably expressing each APOE isoform, that APOE4 increases lysosomal trafficking, accumulates in enlarged lysosomes and late endosomes, alters autophagic flux and the abundance of autophagy proteins and lipid droplets, and alters the proteomic contents of lysosomes following internalization. We investigated APOE-related lysosomal trafficking further in cell culture, and found that APOE from the post-Golgi compartment is degraded through autophagy. We found that this autophagic process requires the lysosomal membrane protein LAMP2 in immortalized neuron-like and hepatic cells, and in mouse brain tissue. Several macroautophagy-associated proteins were also required for autophagic degradation and internalization of APOE in hepatic cells. The dysregulated autophagic flux and lysosomal trafficking of APOE4 that we observed suggest a possible novel mechanism that might contribute to AD pathogenesis. This article has an associated First Person interview with the first author of the paper.

Indexed as

Alzheimer DiseaseProteomicsAnimalsApolipoprotein E4Apolipoproteins EAutophagyLysosomesMiceProtein IsoformsApolipoprotein E4Apolipoproteins EProtein IsoformsAlzheimer's diseaseAPOEAPOE4Chaperone-mediated autophagyLC3-associated endocytosis

Identifiers

PMID34982109
PMCPMC8917355
OpenAlexW4205349812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.